Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R

Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R

US Patent 11801296 · Granted Oct 31, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Development of a novel live attenuated African Swine Fever vaccine based in the 2023
Development of a novel live attenuated African Swine Fever vaccine based in the 2023
Continuous stable cell line for identification of infectious African swine fever2023
Continuous stable cell line for identification of infectious African swine fever2023
Genomic deletion in African swine fever vaccine allowing efficient growth in sta2023
Genomic deletion in African swine fever vaccine allowing efficient growth in sta2023
Development of a novel live attenuated African Swine Fever vaccine based in the 2021
Development of a novel live attenuated African Swine Fever vaccine based in the 2021
Live attenuated classical swine fever vaccine based in genetic manipulation of a2017
Live attenuated classical swine fever vaccine based in genetic manipulation of a2017
Rationally developed african swine fever attenuated virus strain protects agains2017
Rationally developed african swine fever attenuated virus strain protects agains2017